Location History:
- Guangdong, CN (2013)
- Shenzhen, CN (2014)
Company Filing History:
1 out of 1 
1 out of 1 Years Active: 2013-2014
Title: Innovations by Jinhua Zhao in Pharmaceutical Development
Introduction
Jinhua Zhao is a notable inventor based in Shenzhen, China, recognized for his contributions to pharmaceutical innovations. With a total of two patents, Zhao has made significant strides in the field of drug development, particularly in anticoagulant therapies.
Latest Patents
Zhao's latest patents include a depolymerized glycosaminoglycan (dTHG) that serves as a potent endogenous inhibitor of factor X. This compound exhibits good anticoagulant and antithrombotic activity, making it valuable for the prevention and treatment of thrombotic diseases. The preparation method for dTHG involves extracting fucosylated glycosaminoglycan from the body wall, followed by depolymerization and purification steps. Another significant patent is for a novel crystalline form of 3,4',5-trihydroxy-stilbene-3-β-D-glucoside (polydatin). This crystalline form has a stable morphology, a defined melting point, and good chemical stability, which enhances its suitability for solid formulations and industrial drug production.
Career Highlights
Zhao has worked with Shenzhen Neptunus Pharmaceutical Co., Ltd. and Shenzhen Neptunus Pharmaceutical Holdings Co., Ltd., where he has contributed to various pharmaceutical projects. His work has focused on developing innovative solutions that address critical health issues.
Collaborations
Zhao has collaborated with notable colleagues, including Hui Kang and Weizhen Zeng, who have contributed to his research and development efforts.
Conclusion
Jinhua Zhao's innovative work in the pharmaceutical industry highlights his commitment to advancing medical science through his patents and collaborations. His contributions are paving the way for new treatments and improved health outcomes.